Department of Hematology/Oncology, Albert Ludwigs University of Freiburg, Freiburg, Germany.
Biol Blood Marrow Transplant. 2011 Mar;17(3):319-29. doi: 10.1016/j.bbmt.2010.09.001. Epub 2010 Sep 15.
Animal and human studies have shown that after allogeneic hematopoietic cell transplantation, epithelial cells containing donor-derived genome emerge. The mechanisms underlying this phenomenon are still unclear. We hypothesized that horizontal transfer of the hematopoietic donor-DNA to the host epithelium confers a possible operating mechanism. In an in vitro model mimicking the lymphocyte-epithelial interaction, we cocultivated keratinocyte HaCaT cells (Y-chromosome negative) with nonapoptotic or apoptotic, CMFDA, or BrdU-labeled hematopoietic Jurkat cells (Y+) and looked for the emergence of HaCaT cells bearing Jurkat genome. We found that DNA can be horizontally transferred from hematopoietic to epithelial cell lines through phagocytosis of apoptotic bodies. The ingested genomic material was also found within the nuclear compartment and in isolated chromosomes obtained from HaCaT metaphases. Both lysosomal inhibition in HaCaT cells and repetitive load of HaCaT cells with apoptotic bodies increased the intercellular and intranuclear DNA delivery. Although recipient cells remained viable and showed to express the foreign DNA, this expression was transient. Taking into consideration these findings of horizontal DNA transfer between hematopoietic and epithelial cells, we evaluated by quantitative microsatellite analysis the amount of donor DNA in 176 buccal swabs obtained from 71 patients after allogeneic transplantation. We found a high amount of donor-DNA (mean 26.6%) in the majority (89.7%) of them, although no donor hematopoietic cells were evident in the samples by immunofluorescence. We propose that the incessant charge of the transplant recipient with donor-DNA and its "inappropriate" intranuclear delivery in host epithelium may explain the emergence of epithelial cells with donor-derived genome.
动物和人体研究表明,异基因造血细胞移植后,会出现含有供体基因组的上皮细胞。这种现象的机制尚不清楚。我们假设造血供体-DNA 向宿主上皮细胞的水平转移赋予了一种可能的作用机制。在模拟淋巴细胞-上皮细胞相互作用的体外模型中,我们将角质形成细胞 HaCaT 细胞(Y 染色体阴性)与非凋亡或凋亡的、CMFDA 或 BrdU 标记的造血 Jurkat 细胞(Y+)共同培养,并寻找出现携带 Jurkat 基因组的 HaCaT 细胞。我们发现,DNA 可以通过吞噬凋亡小体从造血细胞向上皮细胞系水平转移。摄取的基因组物质也存在于 HaCaT 有丝分裂中期获得的核区室和分离的染色体中。HaCaT 细胞中的溶酶体抑制和凋亡小体的重复加载均增加了细胞间和核内 DNA 的传递。尽管受体细胞保持存活并表现出表达外源 DNA,但这种表达是短暂的。考虑到造血细胞和上皮细胞之间水平 DNA 转移的这些发现,我们通过定量微卫星分析评估了 71 例异基因移植后患者的 176 份口腔拭子中的供体 DNA 量。我们发现大多数(89.7%)患者的供体-DNA 含量较高(平均值 26.6%),尽管免疫荧光法在样本中未检测到供体造血细胞。我们提出,移植受者持续接受供体-DNA 的“负荷”及其在宿主上皮细胞中的“不适当”核内传递,可能解释了出现具有供体衍生基因组的上皮细胞的原因。